After a half-century of attempts, psilocybin has finally been synthesized in the lab

August 16, 2017 by Bob Yirka, Medical Xpress report
Credit: CC0 Public Domain

A team of researchers at Friedrich Schiller University Jena has figured how out to make psilocybin, the chemical responsible for creating hallucinations in people who consume the mushrooms that produce it naturally. In their paper published in the journal Angewandte Chemie the team describes isolating the enzymes needed to create the chemical, developing the recipe and creating psilocybin samples in their lab.

People have known of the hallucinogenic effects of eating certain "magic mushrooms" for hundreds or even thousands of years. But it took Albert Hofman's efforts to isolate the psychoactive ingredients in 1958. Since that time, many scientists have tried to figure out how, exactly, mushrooms make so that it can be artificially synthesized and sold as a medicinal drug. Attempts have failed until now. Notably, growing magic mushrooms for commercial use has proven difficult due to the unique attributes of the mushrooms.

To learn how mushrooms naturally create psilocybin, the researchers sequenced the genomes of two of the main types of magic —that allowed them to isolate the genes that were responsible for producing the enzymes that lead to the creation of psilocybin. Next, they engineered fungi and bacteria samples to confirm their initial findings and to learn of the order in which the synthesis took place. As it turned out, there were four enzymes involved in the process, but after more study, the researchers found that only three of them (PsiD, PsiK, and PsiM) were needed to make the chemical in the lab.

Using this information, the researchers developed a "one pot reaction" recipe for creating psilocybin on demand, utilizing the enzymes they had isolated. They then created samples of psilocybin in their lab—the first team ever to do so.

Their efforts may pave the way for commercial production of psilocybin as a pharmaceutical drug for use in treating such as depression or anxiety, or even for smoking cessation.

Explore further: Active ingredient in magic mushrooms reduces anxiety and depression in cancer patients

More information: Janis Fricke et al. Enzymatic synthesis of psilocybin, Angewandte Chemie International Edition (2017). DOI: 10.1002/anie.201705489

Related Stories

Active ingredient in magic mushrooms reduces anxiety and depression in cancer patients

December 10, 2015
A single dose of psilocybin, the major hallucinogenic component in magic mushrooms, induces long-lasting decreases in anxiety and depression in patients diagnosed with life-threatening cancer according to a new study presented ...

Researchers urge caution around psilocybin use

December 30, 2016
In a survey of almost 2,000 people who said they had had a past negative experience when taking psilocybin-containing "magic mushrooms," Johns Hopkins researchers say that more than 10 percent believed their worst "bad trip" ...

Magic mushroom compound psilocybin could provide new avenue for antidepressant research

May 17, 2016
Psilocybin - a hallucinogenic compound derived from magic mushrooms - may offer a possible new avenue for antidepressant research, according to a new study published in The Lancet Psychiatry today.

Psilocybin reduces psychological pain after social exclusion

April 18, 2016
Social problems are key characteristics in psychiatric disorders and are insufficiently targeted by current treatment approaches. By applying brain imaging methods, researchers at the University of Zurich now show that a ...

fMRI brain imaging illuminates magic mushrooms' psychedelic effects

January 23, 2012
Brain scans of people under the influence of the psilocybin, the active ingredient in magic mushrooms, have given scientists the most detailed picture to date of how psychedelic drugs work. The findings of two studies being ...

Recommended for you

Discovery of inner ear function may improve diagnosis of hearing impairment

October 15, 2018
Results from a research study published in Nature Communications show how the inner ear processes speech, something that has until now been unknown. The authors of the report include researchers from Linköping University, ...

Team's study reveals hidden lives of medical biomarkers

October 12, 2018
What do medical biomarkers do on evenings and weekends, when they might be considered off the clock?

Widespread errors in 'proofreading' cause inherited blindness

October 12, 2018
Mistakes in "proofreading" the genetic code of retinal cells is the cause of a form of inherited blindness, retinitis pigmentosa (RP) caused by mutations in splicing factors.

Researchers create a functional salivary gland organoid

October 11, 2018
A research group led by scientists from Showa University and the RIKEN Center for Biosystems Dynamics Research in Japan have, for the first time, succeeded in growing three-dimensional salivary gland tissue that, when implanted ...

Lassa fever vaccine shows promise and reveals new test for immunity

October 11, 2018
Lassa fever belongs to the same class of hemorrhagic fevers as Ebola. Like Ebola, it has been a major health threat in Western Africa, infecting 100,000-300,000 people and killing 5,000 per year. A new vaccine against both ...

Genetically engineered 3-D human muscle transplant in a murine model

October 10, 2018
A growing need for tissues and organs in surgical reconstruction is addressed by the promising field of tissue engineering. For instance, muscle atrophy results from severe traumatic events including deep burns and cancer, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.